GYRE THERAPEUTICS, INC.

SEC 4 · Filed

0001140361-26-027005Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 10, 2026

Grant, award or other acquisition by Parry Renate

Security
Stock Option (Right to Buy)
Code
A
Shares
40,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-10",
  "direction": "A",
  "exercise_price": "5.95",
  "expiration": "2036-06-10",
  "footnotes": {
    "F1": "This option represents a right to purchase a total of 40,000 shares of the Issuer\u0027s common stock, which will vest in 12 equal monthly installments through June 10, 2027, subject to the Reporting Person\u0027s continued service to the Issuer through each vesting date."
  },
  "owners": [
    {
      "cik": "0001982817",
      "name": "Parry Renate",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "40000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock Option (Right to Buy)",
  "shares": "40000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "40000"
}